These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1239 related items for PubMed ID: 22827747

  • 21. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB, DeCaprio D.
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [Abstract] [Full Text] [Related]

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 23. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 24. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL.
    Methods Enzymol; 2011 Sep; 493():137-55. PubMed ID: 21371590
    [Abstract] [Full Text] [Related]

  • 25. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H, Wetzel S, Kumar K, Waldmann H.
    J Med Chem; 2012 Jul 12; 55(13):5989-6001. PubMed ID: 22537178
    [Abstract] [Full Text] [Related]

  • 26. The devil is still in the details--driving early drug discovery forward with biophysical experimental methods.
    Lundqvist T.
    Curr Opin Drug Discov Devel; 2005 Jul 12; 8(4):513-9. PubMed ID: 16022188
    [Abstract] [Full Text] [Related]

  • 27. The holistic integration of virtual screening in drug discovery.
    Tanrikulu Y, Krüger B, Proschak E.
    Drug Discov Today; 2013 Apr 12; 18(7-8):358-64. PubMed ID: 23340112
    [Abstract] [Full Text] [Related]

  • 28. High-throughput fragment screening by affinity LC-MS.
    Duong-Thi MD, Bergström M, Fex T, Isaksson R, Ohlson S.
    J Biomol Screen; 2013 Feb 12; 18(2):160-71. PubMed ID: 22983162
    [Abstract] [Full Text] [Related]

  • 29. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH, Macarron R.
    Curr Opin Chem Biol; 2010 Jun 12; 14(3):289-98. PubMed ID: 20413343
    [Abstract] [Full Text] [Related]

  • 30. Advances in microfluidics for drug discovery.
    Lombardi D, Dittrich PS.
    Expert Opin Drug Discov; 2010 Nov 12; 5(11):1081-94. PubMed ID: 22827746
    [Abstract] [Full Text] [Related]

  • 31. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D, Ranganathan A, IJzerman AP, Siegal G, Carlsson J.
    J Chem Inf Model; 2013 Oct 28; 53(10):2701-14. PubMed ID: 23971943
    [Abstract] [Full Text] [Related]

  • 32. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE, Pesavento R, Ren J, Lee H, Ratia K, Johnson ME.
    Methods Enzymol; 2018 Oct 28; 610():265-309. PubMed ID: 30390802
    [Abstract] [Full Text] [Related]

  • 33. A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening.
    Luesch H, Abreu P.
    Methods Mol Biol; 2009 Oct 28; 572():261-77. PubMed ID: 20694698
    [Abstract] [Full Text] [Related]

  • 34. A multiplexed approach to hit finding.
    Slack M, Winkler D, Krämer J, Hesterkamp T.
    Curr Opin Drug Discov Devel; 2009 May 28; 12(3):351-7. PubMed ID: 19396736
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T, Bergner A, Sheppard D, Hafenbradl D.
    J Biomol Screen; 2012 Jan 28; 17(1):85-98. PubMed ID: 21990582
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.